BREAKING
6h agoWomen sue the men who used their Instagram feed to create AI porn influencers///6h agoWomen sue the men who used their Instagram feed to create AI porn influencers///
BACK TO GLOSSARY
ORGCompaniesModels

Google DeepMind

29 mentions across all digests

Google DeepMind is Google's AI research division that develops open-weight model families including Gemma 4, a multimodal, agentic model family released under Apache 2.0 license to compete with Chinese open-weights models.

/// Stats
First Seen2026-03-24
Last Seen2026-04-27
Total Mentions29
Subject Mentions22
Last 7 Days3
Sources13
Peak Relevance5/5
Active Predictions2
/// Recent Stories
2026-04-22HIGH

The eighth-generation TPU: An architecture deep dive

Google's TPU 8t and 8i variants eliminate data-preparation bottlenecks with custom Axion CPUs, delivering specialized training and inference hardware optimized for world models and agentic AI at scale.

2026-04-27HIGH

The Man Behind AlphaGo Thinks AI Is Taking the Wrong Path

AlphaGo's David Silver launches Ineffable Intelligence with $1.1B to build superintelligence via self-learning reinforcement systems, rejecting the industry's LLM scaling consensus as inefficient "fossil fuel" AI.

2026-04-27HIGH

What I've been thinking about this weekend - More open questions, intelligence vs power, the problem of verification in science, the parallel discovery of Darwinism

Five hyperscalers control 70%+ of global AI compute with most concentrated at OpenAI, Anthropic, and Google DeepMind — raising questions about whether this concentration prioritizes frontier research over empowering ordinary users and risks pricing the masses out of AI entirely.

2026-04-27HIGH

Google DeepMind Paper Argues LLMs Will Never Be Conscious

DeepMind researcher Alexander Lerchner argues that LLMs are philosophically barred from consciousness by their dependency on human interpretation of outputs—directly challenging CEO narratives about AGI.

2026-04-22HIGH

AI is spitting out more potential drugs than ever. This start-up wants to figure out which ones matter.

10x Science ($4.8M seed) shifts the bottleneck in AI drug discovery from candidate generation to validation—automating the structural analysis and characterization step that remains stubbornly manual.